As many as one-third of previously published randomized clinical trials could be re-analyzed in ways that modify the conclusions of how many or what types of patients need to be treated, according to a new study by researchers at the Stanford University School of Medicine.

 http://scopeblog.stanford.edu/2014/09/09/reanalyses-of-clinical-trial-results-rare-but-necessary-say-stanford-researchers

http://med.stanford.edu/news/all-news/2014/09/re-analysis-of-clinical-trial-data-can-change-conclusions--say-r.html

 http://jama.jamanetwork.com/article.aspx?articleid=1902214

 http://jama.jamanetwork.com/article.aspx?articleid=1902230

 http://www.medicaldaily.com/would-data-sharing-end-crisis-confidence-science-third-clinical-trial-conclusions-may-be-302162

 http://consumer.healthday.com/clinical-trials-information-35/clinical-trials-news-136/reexamined-clinical-trials-often-point-to-new-conclusionsent-findings-691579.html